We are pleased to announce that our Partner, Giacomo Paracchi, has been appointed as a member of the Board of Directors of Genenta Science S.p.A., an innovative Italian biotech company listed on the NASDAQ in New York.
Genenta Science S.p.A. is at the forefront of biotechnology, focused on developing an innovative therapeutic platform for the treatment of solid tumors. Its pipeline includes several candidates and therapeutic combinations, currently in various stages of clinical development.
Francesco Dagnino, Managing Partner of LEXIA, commented: „This appointment is a recognition of the excellence and expertise that Giacomo brings to the fields of corporate law and capital markets.“
Full article on Legalcommunity >
Download Area
Download the PDF
Download
Datum
